Emily Mao
Impact in
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
- Colorectal Cancer Treatments and Studies
- CAR-T cell therapy research
- Pancreatic and Hepatic Oncology Research
-
- Immune Cell Function and Interaction
Papers in
- Oncology 2
- Cancer Immunotherapy and Biomarkers 2
-
- Hepatocellular Carcinoma Treatment and Prognosis 1
- Co-authors
- Adi Diab (2 shared papers)Phillip J. Lum (2 shared papers)Gladis A. Shuttlesworth (2 shared papers)Hamzah Abu‐Sbeih (2 shared papers)Yinghong Wang (2 shared papers)Noman Ali (2 shared papers)John Stroehlein (2 shared papers)Wei Qiao (2 shared papers)
- Journals
- Journal of Hepatology (2 papers)Journal for ImmunoTherapy of Cancer (1 paper)Inflammatory Bowel Diseases (1 paper)
- Partner nations
- United States
In The Last Decade
Emily Mao
4 papers receiving 407 citations
Peers
Comparison fields: 5 of 36
- Oncology 326
- Immunology 65
- Gastroenterology 14
- Epidemiology 86
- Hepatology 9
Countries citing papers authored by Emily Mao
This map shows the geographic impact of Emily Mao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emily Mao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emily Mao more than expected).
Fields of papers citing papers by Emily Mao
This network shows the impact of papers produced by Emily Mao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emily Mao. The network helps show where Emily Mao may publish in the future.
Co-authors
The 25 scholars most cited alongside Emily Mao, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 206 | |
| 2 | 2018 | 201 | |
| 3 | 2018 | 2 | |
| 4 | 2018 | 2 |
About Emily Mao
Emily Mao is a scholar working on Oncology, Hepatology, Epidemiology, Cancer Research and Insect Science, having authored 4 papers that have together received 411 indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (2 papers), Cancer Immunotherapy and Biomarkers (2 papers), Cancer, Lipids, and Metabolism (1 paper) and Hepatocellular Carcinoma Treatment and Prognosis (1 paper). The work is most often cited by research in Oncology (326 citations), Immunology (65 citations), Gastroenterology (14 citations), Epidemiology (86 citations) and Hepatology (9 citations). Emily Mao has collaborated with scholars based in United States. Frequent co-authors include Adi Diab, Phillip J. Lum, Gladis A. Shuttlesworth, Hamzah Abu‐Sbeih, Yinghong Wang, Noman Ali, John Stroehlein, Wei Qiao, Gottumukkala Subba Raju and Faisal S. Ali. Their work appears in journals such as Journal of Hepatology, Journal for ImmunoTherapy of Cancer and Inflammatory Bowel Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.